文献速递关节外科

酶联免疫吸附试验比侧流α防御素试验诊断假体周围关节感染更准确吗

Is the Enzyme-linked Immunosorbent Assay More Accurate Than the Lateral Flow Alpha Defensin Test for Diagnosing Periprosthetic Joint Infection?
PubMed 文献 · Clin Orthop Relat Res · 2018-01-01

该回顾性研究纳入71例行翻修术前关节穿刺的患者,比较定量酶联免疫吸附试验(ELISA)与定性侧流α防御素试验诊断假体周围关节感染(PJI)的准确性。以拟议的欧洲骨与关节感染学会(EBJIS)标准定义PJI时,两种方法敏感性低且无差异(50% vs 46%,p=0.857),特异性均高(98%)。不同定义标准下两者曲线下面积相似,定量与定性α防御素试验确认PJI无差异。

要点

  • 以拟议EBJIS标准定义PJI时,ELISA与侧流α防御素试验敏感性分别为50%和46%,差异无统计学意义(p=0.857)。
  • 两种α防御素试验特异性均为98%(95%CI,88%-100%),差异无统计学意义(p=1.000)。
  • 不同定义标准下两种试验曲线下面积相似(EBJIS p=0.566;IDSA p=0.425;MSIS p=0.339)。

核心结论

  • 定量与定性α防御素试验确认PJI无差异,与所应用的定义标准无关。
  • 定性试验可在10分钟内出结果且无需实验室设施,可能适用于术中环境,但检测费用更高。

研究设计与样本

  • 回顾性研究,样本来自一项相关纵向研究先前采集的样本。
  • 纳入因翻修术前常规检查而行人工髋或膝关节穿刺的患者,2016年10月至2017年4月共73例符合纳入条件,因液体量不足(<5 mL)排除2例,最终分析71例。
  • 71例中54例为膝关节置换、17例为髋关节置换;按拟议EBJIS标准诊断PJI 22例(31%)、无菌性失败49例(69%)。
  • 在关节液中行α防御素ELISA与侧流试验,分别采用MSIS、IDSA和拟议EBJIS标准将患者分类为PJI或无菌性失败,计算敏感性与特异性,并基于受试者工作特征分析比较曲线下面积。
  • 证据等级:Level I,诊断性研究。

主要发现

  • 以拟议EBJIS标准为参照,α防御素ELISA与侧流试验敏感性分别为50%(95%CI,31%-69%)和46%(95%CI,27%-65%),差异无统计学意义(p=0.857)。
  • 以拟议EBJIS标准为参照,两种方法特异性均为98%(95%CI,88%-100%),差异无统计学意义(p=1.000)。
  • 敏感性在采用MSIS标准时最高(ELISA:85%[95%CI,56%-97%],侧流:77%[95%CI];p=0.871),采用IDSA标准时居中(ELISA:73%[95%CI,48%-89%],侧流:67%[95%CI];p=0.867),采用拟议EBJIS标准时最低(ELISA:50%[95%CI,31%-69%],侧流:46%[95%CI];p=0.763)。
  • 无论采用何种标准,特异性均高且两种方法结果无差异(MSIS:98%[95%CI,90%-100%],IDSA:98%[95%CI,90%-100%],EBJIS:98%[95%CI,88%-100%];p=1.000)。
  • 无论采用何种定义标准,α防御素ELISA与侧流试验的曲线下面积相似(EBJIS:p=0.566;IDSA:p=0.425;MSIS:p=0.339)。

关键数值与推荐

  • 以拟议EBJIS标准定义PJI时,ELISA敏感性50%(95%CI,31%-69%),侧流试验敏感性46%(95%CI,27%-65%),p=0.857。
  • 以拟议EBJIS标准定义PJI时,两种方法特异性均为98%(95%CI,88%-100%),p=1.000。
  • 以MSIS标准定义PJI时,ELISA敏感性85%(95%CI,56%-97%),侧流试验敏感性77%(95%CI),p=0.871。
  • 以IDSA标准定义PJI时,ELISA敏感性73%(95%CI,48%-89%),侧流试验敏感性67%(95%CI),p=0.867。
  • 无论采用MSIS、IDSA或拟议EBJIS标准,两种方法特异性均为98%,曲线下面积比较p值分别为0.339、0.425和0.566。

临床怎么用

  • 作者认为,定性侧流α防御素试验可在10分钟内出结果且无需实验室设施,可能适用于术中环境,但检测费用更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alpha defensin was proposed as a new biomarker in synovial fluid for the diagnostic workup of failed joint prostheses. To our knowledge, no comparative study of the performance of the quantitative enzyme-linked immunosorbent assay (ELISA) and qualitative lateral flow alpha defensin test has been reported. QUESTIONS/PURPOSES: (1) Using the proposed European Bone and Joint Infection Society (EBJIS) criteria for defining periprosthetic joint infection (PJI), is there a difference in the diagnostic accuracy of quantitative ELISA and qualitative lateral flow alpha defensin tests? (2) Is there a difference in the performance of the two alpha defensin tests when using three definition classification systems (Musculoskeletal Infection Society [MSIS], Infectious Diseases Society of America [IDSA], and proposed EBJIS)? METHODS: In this retrospective study of samples collected earlier as part of a related longitudinal study, we included patients in whom aspiration of the prosthetic hip or knee was performed as routine investigation before every revision arthroplasty. Between October 2016 and April 2017, a total of 73 patients were eligible for inclusion. As a result of an insufficient fluid volume for analysis (< 5 mL), two patients were excluded. Among the 71 patients in the final analysis, 54 had a knee and 17 a hip arthroplasty. Using the proposed EBJIS criteria, PJI was diagnosed in 22 patients (31%) and aseptic failure in 49 (69%). The alpha defensin ELISA and lateral flow tests were performed in synovial fluid. Patients were classified as having PJI or aseptic failure using the MSIS, the IDSA, and the proposed EBJIS criteria. Sensitivity and specificity of ELISA and the lateral flow alpha defensin test were calculated. Based on receiver operating characteristic analysis, area under the curve values were compared. RESULTS: When measured against the proposed EBJIS criteria, the sensitivity of alpha defensin ELISA and the lateral flow test was low and not different from one another with the numbers available at 50% (95% confidence interval [CI], 31%-69%) and 46% (95% CI, 27%-65%; p = 0.857), respectively, whereas both methods showed high specificity (98% [95% CI, 88%-100%]; p = 1.000). For sensitivity, the highest values were seen when compared against the MSIS criteria (ELISA: 85% [95% CI, 56%-97%], lateral flow: 77% [95% CI]; p = 0.871), intermediate with IDSA criteria (ELISA: 73% [95% CI, 48%-89%], lateral flow: 67% [95% CI]; p = 0.867), and lowest with proposed EBJIS criteria (ELISA: 50% [95% CI, 31%-69%], lateral flow: 46% [95% CI]; p = 0.763). Specificity, however, was high regardless of the criteria used, where ELISA and lateral flow produced results that were not different (MSIS: 98% [95% CI, 90%-100%], IDSA: 98% [95% CI, 90%-100%], EBJIS: 98% [95% CI, 88%-100%]; p = 1.000). The area under the curve of alpha defensin ELISA and the lateral flow test was similar, regardless of the definition criteria used (EBJIS: p = 0.566; IDSA: p = 0.425; MSIS: p = 0.339). CONCLUSIONS: There is no difference between the quantitative and qualitative alpha defensin test for confirmation of PJI, irrespective of applied definition criteria. Having the advantage of providing results within 10 minutes without the need for a laboratory facility, the qualitative test may be of interest in the intraoperative setting, however, at a cost of higher test expense. LEVEL OF EVIDENCE: Level I, diagnostic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Sigmund IK, Yermak K, Perka C, et al. Is the Enzyme-linked Immunosorbent Assay More Accurate Than the Lateral Flow Alpha Defensin Test for Diagnosing Periprosthetic Joint Infection? Clin Orthop Relat Res. 2018. PMID: 30020150. doi:10.1097/CORR.0000000000000336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。